TP53 is reported to be mutated in about 50% of human tumors, including HCC (Brosh and Rotter, 2009; Shen and Ong, 1996; Mutational hotspot in the p53 gene in human hepatocellular carcinomas Hsu IC et al., 1991). This evidence concerns the gene TP53 and hepatocellular carcinoma.